ArticleEuropean radiology experimental2025
Phantom studies in medical imaging (PSMI): a guide with recommendations and checklist.
Article in European radiology experimental, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Reply to the Letter to the Editor: Assessing breast MRI image quality-the bMRI-QUAL scoring system.European radiology · 2026Article
- Development and validation of a 3D printed phantom for image quality assessment in fluoroscopy.Journal of applied clinical medical physics · 2026Article
- Towards an accessible, centralised, searchable database for AI courses in Europe: the Artificial Intelligence in Medical Imaging and Radiation Oncology Education (AIMIROE) project.European radiology experimental · 2026Article
- Instrumentation Digital Twins in PET and SPECT Imaging: Current Status, Challenges, and Future Directions.Computational and structural biotechnology journal · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Phantom studies are essential in medical imaging, offering a controlled and reproducible framework for evaluating imaging technologies across all modalities. Phantoms, whether physical (synthetic, biological, or mixed) or computational, simulate human tissues or anatomical structures and serve roles in technology validation, performance benchmarking, protocol optimization, quality assurance, and artificial intelligence development. We provide recommendations for designing and conducting phantom studies in medical imaging (PSMI). Key aspects include phantom selection, image acquisition protocols, and analysis strategies, particularly when image quality is evaluated in relation to radiation dose or contrast agent optimization. Quantitative image analysis is considered with emphasis on signal-to-noise ratio, contrast-to-noise ratio, and spatial resolution (e.g., modulation transfer function). Qualitative assessment is addressed considering reader selection and training, blinding, randomization, and use of absolute or relative Likert scales. Brief recommendations for sample size calculation, data reporting, and statistical analysis are provided, covering continuous/ordinal data, inter-rater agreement, and group comparisons. A checklist is provided to allow authors to document adherence to these recommendations and to identify shortcomings, limitations, and weaknesses in their phantom studies. The PSMI checklist is proposed to promote transparency, reproducibility, and critical appraisal, containing 25 items regarding: title/abstract (1, 2); background/introduction (3); methods/study design (4); methods/phantom description (5-7); methods/imaging protocol (8, 9); methods/image analysis (10, 11); methods/statistics (12-15); results/quantitative analysis (16, 17); results/qualitative analysis (18); results/tables and figures (19); discussion (20-23); and conclusions (24, 25). Finally, the importance of maintaining a clinical perspective is underscored, highlighting how well-designed phantom studies can inform, but not replace, clinical validation. RELEVANCE STATEMENT: This paper provides comprehensive recommendations for designing and conducting PSMI. The use of the PSMI checklist may contribute to increasing the quality of phantom studies. KEY POINTS: Phantom studies provide controlled, reproducible evaluation of imaging technologies. Phantoms simulate human tissues for validation, optimization, and AI development. Good design includes proper phantom selection and analysis strategies. Clinical relevance must guide interpretation; phantoms cannot replace clinical validation. The proposed 25-item PSMI checklist supports transparent and reproducible phantom study reporting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.